ADENOCARCINOMA OF THE RECTUM

This study is testing whether adding two targeted drugs (tucatinib and trastuzumab) to standard chemotherapy before surgery can help shrink tumors in people with a specific type of rectal cancer (HER2-positive). The main goal is to see if this combination leads to a complete disa…

This study is testing whether a simple at-home stool test can reliably detect returning polyps or cancer in people who have already been treated for early-stage colon cancer. Researchers will compare the results of the stool test to the standard follow-up method, a colonoscopy. T…

This study aims to learn how rectal cancer responds to standard chemotherapy and radiation treatment. Researchers will collect blood, tissue, and scan data from 30 patients to see if these measurements can predict whether their cancer improves, worsens, or stays the same after tr…

This study aims to better understand how liver tumors respond to a targeted radiation treatment called Y90 radioembolization. Researchers will collect small tissue samples from participants' tumors after treatment to examine the effects. The findings could help improve how this t…

This study aims to find the best schedule for follow-up colonoscopies in people who have had 1-2 small, low-risk polyps removed. It will compare whether getting a follow-up colonoscopy every 10 years is just as effective at preventing colorectal cancer as getting one every 5 year…